A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-07-23) →
What happened
Neuromeka updated the terms of convertible bonds to raise US$82.3M, about 24.2% of its market value.
For context, this raise equals about 24.2% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$82.3M |
| vs. market value | 24.2% |
| Filed | 2026-06-18, [Amended] Material event report (paid-in and bonus issue) |
| Source | DART rcept 20260618000105 → open original filing |
Versions of this filing
- 2026-04-24Original
- 2026-06-02Amendment 1
- 2026-06-18Amendment 2 (this page)
- 2026-07-23Amendment 3
Source: DART. Information only, not investment advice.